Ovarian cancer-derived IL-4 promotes immunotherapy resistance.
Mollaoglu G, Tepper A, Falcomatà C, Potak HT, Pia L, Amabile A, Mateus-Tique J, Rabinovich N, Park MD, LaMarche NM, Brody R, Browning L, Lin JR, Zamarin D, Sorger PK, Santagata S, Merad M, Baccarini A, Brown BD.
Mollaoglu G, et al.
Cell. 2024 Oct 25:S0092-8674(24)01154-1. doi: 10.1016/j.cell.2024.10.006. Online ahead of print.
Cell. 2024.
PMID: 39481380